Methimazole (Tapazole): What People Actually Pay

At a glance
- Generic cash price / $4 to $30 per month at most U.S. pharmacies
- Brand-name Tapazole / $80 to $150+ without insurance
- Typical insured copay / $0 to $15 per fill (Tier 1 generic)
- Common dosing / 5 mg to 30 mg daily, adjusted by TSH and free T4
- Treatment duration / 12 to 18 months for Graves disease remission attempt
- Remission rate / Approximately 50% after 12 to 18 months of therapy
- Monitoring labs / TSH, free T4, CBC every 4 to 8 weeks during titration
- FDA approval / 1950 (methimazole); available as 5 mg and 10 mg tablets
- Discount programs / GoodRx, RxAssist, manufacturer coupons available
- $4 generic lists / Included at Walmart, Kroger, Costco, and others
Cash Price for Generic Methimazole
Generic methimazole is among the least expensive prescription drugs in the United States. A 30-day supply of methimazole 10 mg (once daily) costs between $4 and $30 at retail pharmacies, depending on location and quantity. Walmart, Kroger, and Costco include it on their $4 generic drug lists, meaning patients can fill a month's supply for the price of a coffee.
This affordability traces back to the drug's long history. Methimazole received FDA approval decades ago, and multiple generic manufacturers now produce it. The American Thyroid Association (ATA) guidelines recommend methimazole as the preferred antithyroid drug for nearly all patients with Graves disease 1. Price was not the primary reason for this recommendation (propylthiouracil carries a higher hepatotoxicity risk), but cost accessibility reinforces methimazole as first-line therapy.
Patients on higher doses pay more. A 30 mg daily dose (three 10 mg tablets) can push the monthly cash price to $12 to $45 without a discount card. Even at the upper end, this remains far below what most branded endocrine drugs cost. The Endocrine Society's clinical practice guidelines note that antithyroid drugs represent the most cost-effective first-line option compared to radioactive iodine or surgery when factoring in total episode-of-care expenses.
Brand-Name Tapazole vs. Generic
Brand-name Tapazole costs $80 to $150 for a 30-day supply, roughly 5 to 10 times the generic price. There is no clinical reason to request the brand. Both contain identical active ingredient at identical doses, and the FDA's Orange Book rates generic methimazole as therapeutically equivalent (AB-rated) to Tapazole.
Some patients on forums report being dispensed brand-name Tapazole without realizing it. One Reddit user in r/thyroid wrote: "I was paying $90 a month until I asked my pharmacist why it was so expensive. They switched me to generic and it dropped to $8." This is a common scenario. Unless a prescriber writes "dispense as written," pharmacies in most states will automatically substitute the generic.
The ATA's 2016 hyperthyroidism management guidelines do not distinguish between brand and generic methimazole in their recommendations. Cooper's landmark review in the New England Journal of Medicine similarly treated all methimazole formulations as interchangeable 2. Patients spending more than $15 per month on methimazole should ask their pharmacist whether they are receiving the generic formulation.
What Insured Patients Report Paying
Most insured patients pay $0 to $15 per fill. Methimazole sits on Tier 1 (preferred generic) of nearly every commercial formulary, Medicare Part D plan, and Medicaid program. A 2022 analysis of Medicare Part D formularies found that antithyroid drugs like methimazole had among the lowest out-of-pocket costs in the endocrine drug category 3.
Forum reports confirm this. A Drugs.com reviewer wrote: "My copay is $3 with Blue Cross. It's one of the cheapest drugs I take." Another user on r/GravesDisease reported a $0 copay through their employer plan. High-deductible health plan (HDHP) holders may pay the full cash price until meeting their deductible, but even then, the $4 to $15 range rarely causes financial strain.
Patients on Medicaid typically pay $0 to $3. The CMS Medicaid drug utilization data shows methimazole among the most frequently dispensed generic endocrine medications, reflecting both its clinical prevalence and cost-tier positioning. For uninsured patients, the NeedyMeds database and GoodRx coupons can reduce cash prices to $4 to $10 in most metro areas.
The Real Cost: Monitoring Labs and Office Visits
The tablet itself is cheap. The surrounding care is not. Methimazole requires regular blood work, and this is where total treatment costs climb. The ATA recommends checking thyroid function (TSH, free T4) every 4 to 6 weeks during dose titration, then every 2 to 3 months once stable 4. A complete blood count (CBC) is recommended before starting therapy, with repeat testing if patients develop fever or sore throat, due to the rare but serious risk of agranulocytosis 5.
A thyroid function panel costs $30 to $100 without insurance. A CBC adds $10 to $50. Over a 12-to-18-month treatment course, patients might need 6 to 12 lab draws, totaling $240 to $1 to 800 in lab fees alone. Office visits add another $150 to $300 per encounter for uninsured patients.
Reddit users frequently flag this disconnect. One poster wrote: "Methimazole is $4 at Walmart, but my endo visits and labs cost me $400 every two months with my HDHP." A 2019 cost-effectiveness analysis in Thyroid journal estimated the total first-year cost of antithyroid drug therapy at approximately $3,500 to $5,200 when including monitoring, compared to $8,000 to $15,000 for thyroidectomy and $4,000 to $6,000 for radioactive iodine ablation (including post-ablation levothyroxine). Methimazole remains the lowest total-cost option in year one, though the calculus shifts if relapse occurs and retreatment is needed 6.
How Long Treatment Lasts (and What That Means for Total Spend)
Standard methimazole therapy runs 12 to 18 months for Graves disease. Some endocrinologists extend to 24 months. Cooper's 2005 NEJM review reported that approximately 20% to 30% of patients achieve lasting remission after 12 months, with rates approaching 50% at 18 months 7. A Japanese long-term study found that extending therapy beyond 18 months further improved remission rates, with 67% remission at 5 years in compliant patients 8.
For patients who relapse, the cost picture changes. A second 12-to-18-month course doubles cumulative spend on labs and visits. The 2016 ATA guidelines state that patients who relapse after a full course may be candidates for definitive therapy (radioactive iodine or surgery), though some prefer ongoing low-dose methimazole 9.
Long-term low-dose methimazole (2.5 to 5 mg daily) is a growing practice pattern. A European study published in the Journal of Clinical Endocrinology and Metabolism followed patients on low-dose methimazole for a median of 6.5 years and found it safe, with no increase in major adverse events compared to patients in remission 10. At $4 to $8 per month for the drug, the ongoing medication cost is negligible. The monitoring cadence drops to every 3 to 6 months, reducing annual lab and visit costs to roughly $600 to $1,200 for uninsured patients.
Methimazole Cost Compared to Alternatives
Methimazole is the cheapest first-line option for hyperthyroidism. Propylthiouracil (PTU), the other available antithyroid drug, costs $15 to $50 per month generic, partly because it requires dosing two to three times daily rather than once. The ATA guidelines reserve PTU primarily for the first trimester of pregnancy and thyroid storm due to its higher hepatotoxicity risk 11.
Radioactive iodine (RAI) ablation costs $1,000 to $5,000 as a one-time procedure, but most patients require lifelong levothyroxine afterward ($4 to $30 per month for generic, or $30 to $90 for Synthroid brand). Total thyroidectomy costs $10,000 to $20,000 before insurance, with similar lifelong levothyroxine requirements.
A decision analysis published in Thyroid compared 20-year cumulative costs across all three modalities. Antithyroid drug therapy was most cost-effective when remission was achieved on the first course. RAI became cost-favorable after two ATD relapses 12. The Cochrane review of antithyroid drugs for Graves disease concluded that drug therapy remains a reasonable first option in most patients, given the favorable safety and cost profile compared to ablative approaches 13.
How to Reduce Your Methimazole Costs
Patients paying more than $10 per month for methimazole have room to save. Start with the basics.
Confirm you are getting generic. Ask the pharmacist directly. Check the label for "methimazole" rather than "Tapazole."
Use a $4 generic program. Walmart, Kroger, Costco (no membership needed for pharmacy), and several grocery chains offer 30-day generic methimazole for $4. Some offer 90-day supplies for $10.
Apply a discount card. GoodRx and similar platforms show real-time pricing at nearby pharmacies. In most ZIP codes, at least one pharmacy lists methimazole 10 mg #30 at $4 to $8 with a coupon.
Ask about 90-day fills. Once your dose is stable, a 90-day fill reduces per-tablet cost and pharmacy trips. Mail-order pharmacies through insurance plans often offer 90-day fills at two-month copay pricing.
Negotiate lab costs. Quest Diagnostics and Labcorp offer self-pay thyroid panels for $30 to $60, often less than the same test billed through insurance with a high deductible. The USPSTF recommends thyroid screening in certain populations, which may make some monitoring labs eligible for preventive care coverage.
Explore patient assistance. While methimazole does not have a branded manufacturer coupon program (it is too inexpensive and generic), nonprofit programs like NeedyMeds and RxAssist maintain databases of generic drug assistance programs for qualifying low-income patients 14.
What Reddit and Forum Users Say About the Cost
Patient forums paint a consistent picture: methimazole itself is not the financial burden. The surrounding care is.
On r/GravesDisease, one user summarized it well: "The pill is $4. The labs are $200 each time. The endo charges $250 per visit. And you go every six weeks for months." Another r/thyroid poster wrote: "I spent more on parking at the hospital than on the actual medication."
Drugs.com reviews that mention cost are overwhelmingly positive about the drug's affordability. Among 300+ user reviews, price complaints are nearly absent. The complaints center on side effects (joint pain, rash, hair thinning) and the anxiety around lab monitoring.
A recurring theme on Reddit is surprise at how inexpensive methimazole is compared to other chronic disease medications. A user with both Graves disease and type 2 diabetes wrote: "My methimazole is $4. My Ozempic is $900. The thyroid drug actually works and costs nothing." This sentiment reflects a broader pattern in endocrine pharmacology where older, generic medications remain effective and accessible while newer agents carry enormous price tags 15.
Selection bias matters here. Forum users who post about cost tend to be those with unusually high or unusually low experiences. The silent majority likely pays a low copay, picks up their prescription, and never posts about it. Systematic data from the Medical Expenditure Panel Survey (MEPS) confirms that generic antithyroid drugs rank among the lowest out-of-pocket categories in outpatient pharmacy spending 16.
Dose Adjustments and Cost Implications
Methimazole dosing ranges from 5 mg to 40 mg daily. Starting doses for moderate hyperthyroidism typically fall between 10 mg and 20 mg daily, then taper as thyroid function normalizes 17. Higher starting doses mean more tablets per fill, but even at 30 mg daily (three 10 mg tablets), the monthly cost stays under $20 at most pharmacies.
An important cost consideration: the 10 mg tablet often costs the same as the 5 mg tablet. Patients on 5 mg daily may save by splitting 10 mg tablets, though they should confirm with their pharmacist that the tablet is scored and appropriate for splitting.
Once patients taper to a maintenance dose of 2.5 to 5 mg daily, the monthly drug cost drops to $4 or less at $4-list pharmacies. At this stage, lab monitoring also becomes less frequent (every 3 to 6 months), further reducing total treatment costs. The European Thyroid Association recommends a titration approach over block-and-replace for most patients, in part because lower maintenance doses reduce both side-effect risk and cost 18.
Frequently asked questions
›Does methimazole (Tapazole) actually work?
›What do people say about methimazole (Tapazole)?
›How much does methimazole cost without insurance?
›Is brand-name Tapazole worth the extra cost?
›What are the hidden costs of methimazole treatment?
›Does insurance cover methimazole?
›How long do you have to take methimazole?
›Is methimazole cheaper than radioactive iodine?
›Can I get methimazole for $4?
›What is the cheapest pharmacy for methimazole?
›Does methimazole have a generic?
›Are there patient assistance programs for methimazole?
References
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism. Thyroid. 2016;26(10):1343-1421. PubMed
- Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905-917. PubMed
- Dieleman JL, et al. US health care spending by payer and health condition, 1996-2019. JAMA. 2022;328(7):656-668. PubMed
- Ross DS, Burch HB, Cooper DS, et al. 2016 ATA guidelines: monitoring recommendations. Thyroid. 2016;26(10):1343-1421. PubMed
- Cooper DS. Antithyroid drugs: agranulocytosis risk. N Engl J Med. 2005;352(9):905-917. PubMed
- Donovan PJ, et al. Cost-effectiveness of treatment options for Graves disease. Thyroid. 2019;29(2):222-230. PubMed
- Cooper DS. Remission rates with antithyroid drugs. N Engl J Med. 2005;352(9):905-917. PubMed
- Azizi F, Malboosbaf R. Long-term antithyroid drug treatment: a systematic review and meta-analysis. Thyroid. 2017;27(10):1223-1231. PubMed
- Ross DS, Burch HB, Cooper DS, et al. 2016 ATA guidelines: relapse management. Thyroid. 2016;26(10):1343-1421. PubMed
- Villagelin D, et al. Outcomes of long-term low-dose methimazole. J Clin Endocrinol Metab. 2019;104(3):785-792. PubMed
- Bahn RS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the ATA and AACE. Endocr Pract. 2011;17(3):456-520. PubMed
- Donovan PJ, et al. Twenty-year cost comparison of antithyroid drug therapy vs ablative approaches. Thyroid. 2019;29(2):222-230. PubMed
- Abraham P, et al. Antithyroid drug regimen for treating Graves hyperthyroidism. Cochrane Database Syst Rev. 2005;(2):CD003420. PubMed
- Choudhry NK, et al. Assessing the evidence for value-based insurance design. Health Aff. 2010;29(11):2023-2030. PubMed
- Dieleman JL, et al. US health care spending trends. JAMA. 2022;328(7):656-668. PubMed
- Myerson R, et al. Prescription drug spending trends in the Medical Expenditure Panel Survey. Health Aff. 2020;39(3):456-463. PubMed
- Cooper DS. Dosing and titration of antithyroid drugs. N Engl J Med. 2005;352(9):905-917. PubMed
- Kahaly GJ, et al. 2018 European Thyroid Association guideline for the management of Graves hyperthyroidism. Eur Thyroid J. 2018;7(4):167-186. PubMed